PTHS

Insider trade Sale by Francis Knuettel II (CFO, Treas & Secty)

6d ago

SEC filing PTHS Announces CEO Plesha to Speak at Piper Sandler Biopharma Symposium, Xepi/Xeglyze Acquisitions, $175M 2028 Revenue Outlook

49d ago

Insider trade Sale by Peter Greenleaf

56d ago

Insider trade Sale by Matthew Pauls

56d ago

Insider trade Sale by Friedberg Ezra M

56d ago

Insider trade Sale by Richard Malamut

56d ago

News Pelthos signals continued ZELSUVMI momentum and targets expanded product launches through 2027

75d ago

News Pelthos Therapeutics GAAP EPS of -$6.87 misses by $3.84, revenue of $9.39M beats by $0.3M

75d ago

SEC filing PTHS Reports $16.2M ZELSUVMI Net Revenue, $16.8M Total Revenue, 129% QoQ Units, $18M Cash, $30M Term Loan

75d ago

News Pelthos Therapeutics raises $50 mln senior secured loan facility

140d ago

News Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

148d ago

News Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

153d ago

News Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn

153d ago

News FEMSelect Expands Pelvic Health Platform Through Strategic Distribution Agreement with ARMS Medical

168d ago

News Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

169d ago